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Abstract
Background: The development of antinociceptive tolerance following repetitive administration of opioid analgesics
significantly hinders their clinical use. Evidence has accumulated indicating that microglia within the spinal cord
plays a critical role in morphine tolerance. The inhibitor of microglia is effective to attenuate the tolerance;
however, the mechanism is not fully understood. Our present study investigated the effects and possible
mechanism of a natural product procyanidins in improving morphine tolerance via its specific inhibition on
NOD-like receptor protein3 (NLRP3) inflammasome in microglia.
Methods: CD-1 mice were used for tail-flick test to evaluate the degree of pain. The microglial cell line BV-2 was
used to investigate the effects and the mechanism of procyanidins. Reactive oxygen species (ROS) produced from
BV-2 cells was evaluated by flow cytometry. Cell signaling was measured by western blot assay and
immunofluorescence assay.
Results: Co-administration of procyanidins with morphine potentiated its antinociception effect and attenuated the
development of acute and chronic morphine tolerance. Procyanidins also inhibited morphine-induced increase of
interleukin-1β and activation of NOD-like receptor protein3 (NLRP3) inflammasome. Furthermore, procyanidins
decreased the phosphorylation of p38 mitogen-activated protein kinase, inhibited the translocation of nuclear
factor-κB (NF-κB), and suppressed the level of reactive oxygen species in microglia.
Conclusions: Procyanidins suppresses morphine-induced activation of NLRP3 inflammasome and inflammatory
responses in microglia, and thus resulting in significant attenuation of morphine antinociceptive tolerance.
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Background
Morphine as the gold standard for treating pain is widely
used in clinic. However, long-term use of morphine
leads to analgesic tolerance, which greatly reduces the
utilization of this drug. The mechanism of morphine
tolerance is complicated involving many aspects, such as
receptors, ion channels and neural networks [1–3].
For a long period, most investigations focused mor-
phine tolerance on neurons. A lot of evidences suggest
that morphine activates opioid receptors, resulting in an
endocytosis of μ-opioid receptor (MOR) and upregulated
expression of N-methyl-D-aspartic acid (NMDA) recep-
tors in the cell surface [4–7]. The phosphorylated
NMDA receptors exhibit an enhanced calcium conduct-
ance [8], leading to an upregulation of protein kinase C
(PKC) [6, 9, 10], which potentiates neuronal excitability
and finally lead to opiate tolerance.
However, compelling evidences reported recently have
shown that morphine tolerance is also due to the activa-
tion of microglia [11–13]. Chronic morphine exposure
induces persistent activation of spinal cord microglia
[14, 15]. Studies demonstrate that morphine binds to
Toll-like receptor 4 (TLR4), leading to the initiation of
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innate immune signaling cascade and the production of
proinflammatory factors [16].
The microglia activated by morphine releases proinflam-
matory cytokines, including interleukin (IL)-1β, tumor ne-
crosis factor (TNF)-α, and IL-6 [6]. These cytokines
enhance the hyperactivity of dorsal horn neurons, which
cause the central sensitization and reduction in morphine
analgesic efficacy [17]. As the most important factor in in-
flammatory processes [18], IL-1β has a unique molecular
mechanism for its maturation in an intracellular multipro-
tein complex named as inflammasome. In microglia, pro-
IL-1β was processed by NOD-like receptor protein3
(NLRP3) inflammasome and then the mature IL-1β was
secreted [19].
NLRP3 is a unique inflammasome whose assembly
and activation involves a two-step process. Firstly, a
priming signal stimulates TLR4 and then enhances NF-
κB-driven transcription of NLRP3 [20]. Then a second
signal promotes NLRP3 to form a protein complex with
apoptosis-associated speck-like protein (ASC) containing
a caspase recruitment domain [21–23].
Currently, there are three models of NLRP3 activation
to illuminate this process. First, the generation of react-
ive oxygen species (ROS) is considered to be critical for
activation of NLRP3 inflammasome. ROS induces the
dissociation of thioredoxin and then activates NLRP3
[24]. Second, extracellular ATP binds to P2X7R and trig-
gers K+ efflux, which is a sufficient signal for NLRP3 ac-
tivation [25–27]. Then, a third model has been proposed
that certain particulate activators can activate NLRP3
inflammasome by Cathepsin B released from destabilized
lysosomal compartment [28].
The function of NLRP3 inflammasome is crucial for the
regulation of neuroinflammation mediated by microglia
[19]. Therefore, compounds that inhibit the activation of
NLRP3 inflammasome may contribute to the improvement
of morphine tolerance. Procyanidins is a potent and safe
natural product usually extracted from grape seed. It in-
cludes a structurally diverse set of compounds, with poten-
tially hundreds of individual compounds with anti-oxidant,
anti-inflammatory, and anti-allergic activities [29–31]. Fur-
thermore, procyanidins is available from a wide variety of
dietary sources: grapes, nuts, cocoa, apples, peaches, ber-
ries, pears, cranberries, and peanuts. Recently, it was recog-
nized as health protective agent [32, 33]. Epidemiological
studies indicated that populations consuming procyanidins-
rich foods had lower incidences of inflammatory diseases,
including metabolic syndrome and atherosclerosis [34, 35].
There is a large number of scientific evidence manifesting
the inhibitory effects of procyanidins on inflammation [36].
Herein, we demonstrate for the first time that mor-
phine can activate microglial NLRP3 inflammasome.
Moreover, procyanidins, a safe and effective natural
product, can attenuate morphine tolerance by inhibiting
the NLRP3 activation of inflammasome and the matur-




All procedures were strictly performed in accordance with
the regulations of the ethics committee of the Inter-
national Association for the Study of Pain and the Guide
for the Care and Use of Laboratory Animals (The Ministry
of Science and Technology of China, 2006). All animal
experiments were approved by the Nanjing Medical
University Animal Care and Use Committee, and were de-
signed to minimize suffering and the number of animals
used.
Animals
Adult CD-1 mice (18–22 g) were provided by the Experi-
mental Animal Center at Nanjing Medical University,
Nanjing, China. Mice were housed five to six per cage
under pathogen-free conditions with soft bedding under
controlled temperature (22 ± 2 °C) and a 12 h light/dark
cycle (lights on at 8:00 a.m.). Behavioral testing was
performed during the light cycle (between 9:00 a.m. and
5:00 p.m.). Mice were allowed to acclimate to these condi-
tions for at least 2 days before inclusion in experiments.
For each group of experiments, the animals were matched
by age and body weight.
Reagents
Procyanidins was purchased from Zelang Pharmaceutical
Co. Ltd (Nanjing, China). The purity of procyanidins was
more than 95 %. Procyanidins contained 1.1 % monomeric,
34.2 % dimeric, 24.9 % trimeric, 6.7 % tetrameric (totally
66.9 % oligomeric procyanidins), and 33.1 % polymeric pro-
cyanidins. IL-1β was from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Antibodies for caspase-1 and NLRP3 were
acquired from Adipogen International (San Diego, CA,
USA). Antibody for glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) was from Sigma-Aldrich (St. Louis, MO,
USA). Antibody for ionized calcium-binding adapter mol-
ecule 1 (IBA-1) was from Wako Pure Chemical Industries
(Osaka, Japan). The antibodies for p38, c-Jun N-terminal
kinase (JNK), extracellular-regulated protein kinases (ERK),
NMDA-NR1, PKC, p65/RelA, and immunofluorescent
antibody for IBA-1 were from Abcam (Cambridge,
MA, USA). Antibodies for phosphorylated NR1 sub-
unit (Ser896), phosphorylated PKC (pan) (gamma
Thr514), phosphorylated p38 (Tyr182), phosphorylated
ERK (Thr202/Tyr204), phosphorylated JNK (Thr183/
Tyr185) and immunofluorescent antibody for c-fos were
from Cell Signaling Technology (Beverly, MA, USA). Im-
munofluorescent antibody for calcitonin gene related pep-
tide (CGRP) was from Santa Cruz Biotechnology (Santa
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Cruz, CA, USA). Lipopolysaccharide (LPS), rotenone, di-
methyl sulfoxide (DMSO), and ATP were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Morphine hydro-
chloride was purchased from Shenyang First Pharmaceut-
ical Factory, Northeast Pharmaceutical Group Company
(Shenyang, China). Fetal bovine serum (FBS) was pur-
chased from Gibco, and other cell culture media and
supplements were purchased from HyClone (Logan,
UT, USA). 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-
tetrazolium bromide (MTT) was purchased from Sun-
shine Biotechnology (Nanjing, China). MitoSOX was pur-
chased from Thermo Fisher Scientific (Waltham, MA,
USA). All other reagents were from Sigma-Aldrich (St.
Louis, MO, USA).
Cell preparation and stimulation
BV-2 cells were maintained in humidified 5 % CO2 at
37 °C in Dulbecco’s modified Eagle’s Medium (DMEM)
supplemented with 10 % (v/v) FBS, penicillin (100 U/ml),
and streptomycin (100 U/ml). For inducing inflammasome
activation, 105 cells were plated in 6-well plate overnight
and the medium were changed to serum-free medium in
the following morning and then the cells were treated
with morphine (200 μM) or LPS (1 μg/ml) with or without
procyanidins (1‰ DMSO) for 12 h. We performed the
DMSO-only as the control. After that, the BV-2 cells were
stimulated with ATP (5 mM) for 1 h. Cell extracts and pre-
cipitated supernatants were analyzed by immunoblotting.
Tolerance models and behavioral analysis
We habituated animals in the testing environments for
2 days and carried out behavioral testing in a blinded man-
ner. For the test of chronic tolerance, mice were injected
with saline or morphine (10 mg/kg) subcutaneously every
12 h for 7 days and analgesia was assessed 0.5 h after mor-
phine administration by the tail-flick assay every morning
[15]. Briefly, mice’s tails were placed in 55 °C hot water, and
the latency of tail withdrawal was measured. A cut-off time
of 30 s was set to avoid tissue damage. Procyanidins was
suspended in 0.5 % sodium carboxymethyl cellulose (CMC-
Na). Procyanidins (20, 40, or 80 mg/kg) was administered
intragastrically 15 min before morphine given twice a day
from day 1 to day 7.
Measurement of cytokines
Mouse IL-1β in supernatants from cell culture were
determined using the ELISA kits (R&D Systems,
Minneapolis, MN, USA) according to manufacturer’s
instructions. Level of malondialdehyde (MDA) was
assayed with kits from Nanjing Jiancheng Bioengineer-
ing Institute (Nanjing, China) according to manufac-
turer’s instructions.
NF-κB activation assay
BV-2 cells were plated in class bottom cell culture dishes
and treated with morphine (200 μM) for 4 h with or
without procyanidins (100 μM). Then BV-2 cells were
fixed with ice-cold methanol and were permeabilized
with 0.25 % Triton X-100/PBST. After blocking with 1 %
bovine serum albumin (BSA) in PBST for 1 h, the cover-
slips with BV-2 cells were incubated for 2 h at room
temperature with the p65/RelA antibody diluted in 1 %
BSA (1:50). Then the coverslips were exposed to the
fluorescein isothiocyanate (FITC)-conjugated anti-rabbit
IgG (1:100, at room temperature for 1 h) and then were
rinsed three times with PBS. Finally, the coverslips were
stained with 1 μg/mL DAPI (4′,6-diamidino-2-phenylin-
dole, a fluorescent DNA dye to mark nucleus) for 1 min.
Confocal microscopy analyze was carried out using
Olympus FV1000 confocal system.
ROS measurement
BV-2 cells were plated in non-tissue-culture-treated six-
well dishes and stimulated with morphine (200 μM) for
12 h with or without the pre-treatment of procyanidins
(100 μM). A positive control was stimulated with rotenone
(10 μM) for 6 h. After the cultivation, supernatant was re-
moved and cells were washed with PBS. Then the cells
were incubated with MitoSOX (to measure mitochondria-
associated ROS levels) at 2.5 μM in serum-free DMEM for
0.5 h at 37 °C. After that, cells were washed with warm
PBS, removed from plates with cold PBS containing 1 %
FBS, and subjected to fluorescence-activated cell sorting
(FACS) analysis (Miltenyi MACSQuant Analyzer 10,
Germany). The data were analyzed using FlowJo statistical
software (Emerald Biotech Co., Ltd).
Western blot
Samples (cells or spinal cord tissue segments at L1-L6)
were collected and washed with ice-cold PBS before
being lysed in radio immunoprecipitation assay (RIPA)
lysis buffer [Beyotime, Shanghai, China; 50 mmol/L
Tris (pH 7.4), 150 mmol/L NaCl, 1 % Triton X-100,
1 % sodium deoxycholate, 0.1 % sodium dodecyl sulfate,
1 mmol/L phenylmethylsulfonyl fluoride, 0.15 U/mL apro-
tinin, and 1 mg/mL pepstatin] and then sample lysates
were separated by SDS-PAGE and electrophoretically
transferred onto polyvinylidene fluoride membranes
(Millipore Corp., Bedford, MA, USA). The membranes
were blocked with 10 % whole milk in TBST (Tris–HCl,
NaCl, Tween 20) for 2 h at room temperature, probed
with primary antibodies at 4 °C overnight [GAPDH,
1:8000; IBA-1, 1:1000; NLRP3, 1;1000; caspase-1, 1:1000;
IL-1β, 1:500; TNF-α, 1:1000; p-p38 (Tyr182), 1:1000; p38,
1:1000; p-ERK, 1:1000; ERK, 1:1000; p-JNK, 1:1000; JNK,
1:1000; p-NR1(Ser896), 1:1000; NR1, 1:1000; p-PKC,
1:1000; PKC, 1:1000;] and then incubated with horseradish
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peroxidase-coupled secondary antibodies from Cell Sig-
naling Technology (Beverly, MA, USA). Data were ac-
quired with the Molecular Imager (Gel DocTM XR,
170–8170) and analyzed with Quantity One-4.6.5 (Bio-
Rad Laboratories, Berkeley, CA, USA).
Immunofluorescence assay
Under deep anesthesia by intraperitoneal injection of so-
dium pentobarbital (100 mg/kg), the animal was perfused
with normal saline followed by 4 % paraformaldehyde in
0.1 M PBS, pH 7.2–7.4, for 20 min. Then L4 and/or L5
Fig. 1 (See legend on next page.)
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lumbar segment were dissected out and post-fixed in
the same fixative. The embedded blocks were sectioned
as 30-μm thick and processed for immunofluorescence
assay. Sections from each group (five mice in each
group) were incubated with primary antibody (IBA-1,
1:200; c-fos, 1:200; CGRP, 1:200; NeuN, 1:300). Then the
free-floating sections were washed with PBS, and incu-
bated with the secondary antibody (1:300; Jackson Labora-
tories, USA) for 2 h at room temperature. After being
washed three times with PBS, the samples were investi-
gated with a confocal microscope (Leica TCS SPEII, Leica
Biosystems, Wetzlar, Germany) for morphologic details.
Images were randomly coded and transferred to a com-
puter for further analysis.
Statistical analysis
SPSS Rel 15 (SPSS Inc., Chicago, IL, USA) was used to
conduct all the statistical analyses. Data were statistically
evaluated by two-way analysis of variance (ANOVA)
followed by Bonferroni post hoc tests. The mean fluores-
cent pixels of IBA-1 and CGRP were measured by Image
Pro Plus 6.0 (Media Cybernetics, Silver Spring, MD,
USA). Results were represented as mean ± standard error
of the three independent experiments. Results described
as significant were based on a criterion of p < 0.05.
Results
Systemic administration of procyanidins improved the
morphine tolerance and suppressed morphine-induced
microglial activation in the spinal cord
Some experiments were performed to investigate the
role of procyanidins on morphine-induced tolerance in
vivo. Procyanidins did not alter the pain threshold of
mice up to 80 mg/kg. Data suggested that procyanidins
significantly improved acute and chronic morphine tol-
erance (Fig. 1a, b). The MPE decreased to 16.52 % in
chronically morphine-treated mice on day 7. The reduc-
tion in morphine’s MPE was significantly prevented by
twice-daily coadministration of procyanidins (20, 40, or
80 mg/kg, i.g.). MPE decreased to 57.76, 72.88, and
46.11 %, respectively (Fig. 1b).
Subcutaneous injection of morphine induced activa-
tion of microglia in the spinal cord. Western blot and
immunofluorescence data showed that repeated mor-
phine treatment (10 mg/kg, twice a day for 7 days) re-
sulted in an upregulation of the IBA-1 (a microglial
marker) (Fig. 1c, d). Systemic administration of procya-
nidins inhibited morphine-induced microglial activation.
Strikingly, 40 mg/kg procyanidins nearly reversed the in-
crease of IBA-1 (Fig. 1c, d). Procyanidins also signifi-
cantly reduced the upregulation of p38 MAPK
phosphorylation induced by morphine exposure in the
spinal cord (Fig. 1c). These data provided additional evi-
dences that procyanidins could inhibit morphine-
induced microglia activation.
Procyanidins inhibited morphine-induced NLRP3
inflammasome activation in vivo
It was reported that morphine tolerance led to increased
inflammatory response, especially the upregulation of IL-
1β [6, 37]. Our data showed that consistent morphine
exposure (10 mg/kg, twice a day for 7 days) increased pro-
tein levels of the proinflammatory cytokines IL-1β and
TNF-α in mouse spinal cords. The repetitive administra-
tion of procyanidins (i.g., 15 min before each injection of
morphine daily) suppressed the upregulation of proin-
flammatory cytokines in an efficient manner (Fig. 2a, d).
IL-1β was processed by NLRP3 inflammasome in micro-
glia [38]. Our data suggested that morphine exposure
activated NLRP3, and procyanidins could inhibit this acti-
vation (Fig. 2c). Western blot analysis revealed that pro-
cyanidins could significantly reduce the increased protein
levels of the caspase-1 (Fig. 2b) and the NLRP3, which
played a well-established role in neuroinflammation.
MDA level can indirectly reflect attack severity of
the body by ROS. Treatment of mice with morphine
(10 mg/kg, twice a day for 7 days) caused an increase
of the MDA level in the spinal cord, while pre-
treatment with procyanidins markedly attenuated the
increasing level of MDA (Fig. 2e).
Procyanidins attenuated chronic morphine tolerance by
inhibiting the phosphorylation of NMDA-NR1, PKC, and
MAPKs in the spinal cord
Studies show that activated microglia released proin-
flammatory cytokines, such as IL-1β and TNF-α, which
(See figure on previous page.)
Fig. 1 Procyanidins suppressed acute and chronic morphine tolerance via inhibiting microglia in the spinal cord. Tail-flick method was performed
to evaluate the effect of procyanidins on the morphine tolerance. Data (n = 8) were shown as percentage of maximal possible effect (% MPE).
a Procyanidins suppressed acute morphine tolerance. Before the treatment of morphine (10 mg/kg, s.c.), mice were pre-treated with different
doses of procyanidins (i.g.) for 15 min. MPE was measured after morphine 10 mg/kg (s.c.) administration at the first day. b Procyanidins suppressed
chronic morphine tolerance. Morphine was injected subcutaneously twice a day, and the MPE was measured 0.5 h after the first injection of each day.
Before the treatment of morphine (10 mg/kg, s.c.), mice were pre-treated with different doses of procyanidins (i.g.) for 15 min. c Procyanidins inhibited
morphine-induced upregulation of IBA-1 and phosphorylation of p38 MAPK, but not the p38 total protein. Samples were obtained and analyzed 2 h
after morphine treatment on day 7. Representative western blot data (n = 4) for p-p38, p38, and IBA-1 was shown. d Immunofluorescence images and
analysis showed the activation of microglia after morphine injection (n = 4) in the spinal cord. *p < 0.05, **p < 0.01, ***p < 0.001 vs. baseline; #p < 0.05,
##p < 0.01 vs. morphine-treated group. Scale bar 75 μm
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Fig. 2 (See legend on next page.)
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stimulated neuron and glia through IL-1 receptor,
NMDA receptor, and TNF receptor, resulting in the
phosphorylation of PKC and MAPKs [37]. As a result,
morphine tolerance and hyperalgesia were developed.
We investigated the role of procyanidins on morphine-
induced activation of neuron and glia in vivo. Western
blot analysis revealed that procyanidins suppressed the
morphine-induced upregulation of phosphorylated
NMDAR-NR1 subunit and PKC in the spinal cords
(Fig. 3a). Confocal images and immunofluorescence
analysis showed that procyanidins could inhibit the ac-
tivation of neuronal c-fos and CGRP after morphine
treatment in the spinal cord (Fig. 3c, d). Furthermore,
procyanidins also inhibit the increased phosphoryl-
ation of JNK and phosphorylation of ERK after mor-
phine treatment (Fig. 3b).
Procyanidins suppressed morphine-induced NLRP3
inflammasome activation in vitro
To study the effects of procyanidins on morphine-
induced microglial NLRP3 inflammasome activation in
vitro, immortalized murine microglial cell line BV-2 was
used [39, 40]. BV-2 cells were treated with morphine
(200 μM) and different concentrations of procyanidins for
12 h with or without ATP for 1 h. Morphine treatment
triggered the first step of activating NLRP3 inflamma-
some, which enhancing the level of NLRP3 and pro-IL-1β
(Fig. 4a), and activated the second step, leading to the in-
creasing level of IL-1β and caspase-1 in the supernatant
(Fig. 4b, c). Compared with the only morphine-treated
group, pre-administrated group with procyanidins
(100 μM) 15 min before morphine administration signifi-
cantly reduced the level of pro-IL-1β, IL-1β, NLRP3, and
caspase-1 in BV-2 cells (Fig. 4). Moreover, procyanidins
also suppressed the upregulation of NLRP3 inflamma-
some caused by classical TLR4 agonist LPS (Fig. 4) in
microglia.
The p38 MAPK phosphorylation and p65 NF-κB
translocation from the cytoplasm to the nucleus were
shown to promote the maturation of NLRP3 inflamma-
some as the first activation signals in microglia [37].
Compared with the only morphine-treated group, pre-
administrated (15 min) with procyanidins significantly
reduced these effects (Fig. 5a, c). However, in BV-2 cells,
procyanidins (100 μM) alone showed no significant ef-
fects on the phosphorylation of p38 MAPK and the
translocation of p65 NF-κB (Fig. 5a, c). MTT assay
indicated that the different doses of procyanidins did not
affect cell proliferation (Fig. 5b).
Procyanidins as a potent free radical scavenger has dem-
onstrated the ability to clear intracellular ROS. The main
source of cellular ROS is mitochondria [41]. Various
stresses including increased metabolic rates, hypoxia, or
inflammatory response could markedly increase the pro-
duction of mitochondrial ROS, which would activate
NLRP3 inflammasome as the second activation signal in
microglia [38]. To investigate a possible mechanism of
morphine in inflammasome activation, we measured ROS
production in mitochondria by flow cytometry [42]. Mor-
phine significantly increased the level of ROS compared
with the negative and positive control (Fig. 5d). Pre-
administrated (15 min) with procyanidins (100 μM) sig-
nificantly reduced morphine-induced production of ROS
(Fig. 5d) and procyanidins also inhibited the ROS induced
by rotenone (Additional file 1: Figure S1).
Discussion
In this study, we found procyanidins, a clinically used
health product, had a significant inhibitory effect on
morphine-induced activation of microglia by suppressing
NLRP3 inflammasome activation. Therefore, procyani-
dins attenuated the development of acute and chronic
morphine tolerance markedly. This study may provide a
new solution to improve clinical analgesic efficacy of
opioids through the inhibition of microglial NLRP3
inflammasome.
Procyanidins, as safe and effective compounds, can be
absorbed from the gastrointestinal tract when people eat
certain fruits and vegetables. It was usually adminis-
trated orally [43, 44]. However, the oral bioavailability of
procyanidins was about 3–4 %, which was not very satis-
factory though it had reached the standard of many clin-
ically used drugs such as levodopa, a drug used to treat
Parkinson’s disease [44–46]. More fortunately, procyani-
dins was a relatively safe drug with an oral LD50 value of
over 4000 mg/kg. The optimal dose for the attenuation
of morphine tolerance is 40 mg/kg in mice, which equals
to 3.33 mg/kg in human. Therefore, human with a body
weight of 60 kg might intake 400 mg of procyanidins
every day if it is given twice a day. At present, a lot of
commercial nutrition supplements containing procya-
nidins recommend a dosage from 400 to 800 mg every
day. Therefore, procyanidins would be safe and effect-
ive for inhibiting morphine tolerance. These results
(See figure on previous page.)
Fig. 2 Procyanidins suppressed morphine-induced NLRP3 inflammasome activation in the spinal cord. a Procyanidins inhibited the morphine-induced
upregulation of IL-1β in the spinal cord. b Procyanidins suppressed the morphine-induced activation of caspase-1 in the spinal cord. c Procyanidins
inhibited the morphine-induced upregulation of NLRP3 in the spinal cord. d Procyanidins inhibited the morphine-induced upregulation of TNF-α in
the spinal cord. The western blot samples (n = 4) were collected as described in methods. e Procyanidins inhibited the morphine-induced upregulation
of malondialdehyde (MDA) in the spinal cord (n = 4). *p < 0.05, **p < 0.01 vs. baseline; #p < 0.05, ##p < 0.01 vs. morphine-treated group
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Fig. 3 (See legend on next page.)
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Fig. 3 Procyanidins attenuated chronic morphine tolerance by inhibiting the neuron-glia pathway in the spinal cord. a Procyanidins inhibited the
morphine-induced upregulation of phosphorylated PKC and phosphorylated NMDAR-NR1 in the spinal cord. The western blot samples (n = 4)
were collected 2 h after the last morphine treatment. b Procyanidins inhibited the morphine-induced phosphorylation of JNK and ERK in the spinal cord.
The western blot samples (n= 4) were collected as above. c, d Confocal images and immunofluorescence analysis showed the activation of neuronal c-fos
and CGRP after morphine treatment (n= 4) in the spinal cord. The quantification of c-fos and CGRP immunofluorescence was respectively represented as
number of c-fos positive cells and mean fluorescence pixels in the superficial dorsal horns. *p < 0.05, **p < 0.01, ***p < 0.001 vs. baseline; #p < 0.05,
##p < 0.01, ###p < 0.001 vs. morphine-treated group. Scale bar 75 μm
Fig. 4 Procyanidins suppressed morphine-induced NLRP3 inflammasome activation in microglia. BV-2 cells were stimulated by LPS (1 μg/ml) or morphine
(200 μM) with or without 100 μM of procyanidins for 12 h, and then, the inflammasome was activated with 5 mM of ATP for 1 h. a Procyanidins (100 μM)
inhibited both LPS-induced and morphine-induced expression of pro-IL-1β and NLRP3 in BV-2 cells. The western blot samples for BV-2 cells (n= 4) were
collected and analyzed 12 h after the last morphine exposure. b Procyanidins (100 μM) inhibited the morphine-induced and LPS-induced increase of
caspase-1 and IL-1β in the supernatant of BV-2 cells. The western blot samples (n = 4) came from the supernatant of BV-2 cells. c ELISA of
IL-1β in supernatants from LPS- and morphine-primed BV-2 cells and then stimulated with ATP. *p < 0.05, **p < 0.01, ***p < 0.001 vs. baseline;
#p < 0.05, ##p < 0.01, ###p < 0.001 vs. morphine-treated group
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indicate that it may be beneficial for the patients
treated with opiate drugs to actively intake foods rich
in procyanidins, such as: cranberry, blueberry, apple,
cherry, and grape.
In the spinal cord, microglia regulated morphine toler-
ance via TLR4 signaling [47]. When morphine bound
with TLR4, it activated the downstream intracellular sig-
naling pathways similar to those activated by IL-1β
binding to its cognate receptor, resulting in a potent pro-
inflammatory signal (Fig. 6) [6, 48]. Our data showed
that, pre-treatment of procyanidins significantly sup-
pressed the level of IL-1β in vivo and in vitro after mor-
phine exposure. Beside of this, adiministration of
procyanidins alone did not affect the level of proinflam-
matory cytokines (Additional file: 1 Figure S2). In micro-
glia, the NLRP3 inflammasome is a molecular platform
Fig. 5 Procyanidins suppressed morphine tolerance by inhibiting p38 MAPK/NF-κB and ROS signaling in microglia. Before the treatment of morphine
(200 μM), BV-2 cells were pre-treated with different doses of procyanidins. Then we handle and analyze BV-2 cells after morphine exposure. a Procyanidins
inhibited the phosphorylation of p38 MAPK after morphine treatment for 2 h in a dose-dependent manner. Representative western blot bands and a data
summary (n = 4) for p-p38 and p38 are shown. b MTT experiments showed that different doses of procyanidins did not affect cell proliferation.
c Procyanidins (100 μM) inhibited the NF-κB translocation from the cytosol to the nucleus after morphine exposure for 4 h in BV-2 cells. d The
level of ROS was assessed by calculating the ratio of MitoSOX staining positive cells to 10,000 cells through flow cytometry. Procyanidins
(100 μM) inhibited the release of mitochondrial ROS after morphine treatment for 12 h in BV-2 cells. *p < 0.05, **p < 0.01, ***p < 0.001 vs. baseline;
#p < 0.05, ##p < 0.01, ###p < 0.001 vs. morphine-treated group. Scale bar 20 μm
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activated upon signals of cellular “danger” to trigger innate
immune defenses through the maturation of proinflam-
matory cytokines such as IL-1β [38]. We found that pro-
cyanidins could inhibit morphine-induced activation of
NLRP3 inflammasome in vitro in the concentration of
100 μM. Though this concentration seems a little high,
it could be achievable in vivo. Since the oral bioavail-
ability of procyanidins was about 3–4 % [44–46], the
blood concentration of 100 μM might be easily achieved
when 80 mg/kg of procyanidins was given to mice
which had a blood volume of 1.5 ml. However, further
investigations are needed into the preclinical pharmaco-
kinetic evaluation of procyanidins, especially on its dis-
tribution in the central nervous system.
Some studies reported that spinal P2X7R was involved
in the induction but not maintenance of morphine toler-
ance [27]. As previously mentioned, the activation of
P2X7R was viewed as the second signal for the
activation of NLRP3 inflammasome in microglia (Fig. 6).
It was reported that NAC, a ROS inhibitor, decreased
IL-1β synthesis via inhibiting the P2X7R activation in
murine macrophages [49]. Therefore, we could not rule
out that procyanidins inactivated NLRP3 inflammasome
by inhibiting P2X7R after morphine exposure in
microglia.
Mao et al. reported that LPS-induced upregulation of
NLRP3 was suppressed in the morphine-tolerant state,
which may be one of the mechanisms involved in
morphine-induced immunosuppression [50]. But to our
best knowledge, we first confirmed that in the morphine-
tolerant state, morphine could significantly activate
NLRP3 inflammasome in the microglia.
It said before, ROS could induce the dissociation of
thioredoxin and then activate NLRP3 inflammasome
(Fig. 6). Our compound, procyanidins, as a ROS scaven-
ger, significantly inhibited the morphine-induced release
Fig. 6 Schematic indicating the suppression of microglial NLRP3 to alleviate morphine tolerance by procyanidins. Upon the stimulation by
morphine or LPS, several pathways including the release of ROS, and K+ efflux have been identified to signal the activation of NLRP3
inflammasome, leading to the activation of caspase-1 and the maturation of IL-1β. Procyanidins inhibited the ROS production and NLRP3 activation.
The p38/NK-κB pathway was activated by morphine or LPS to induce the gene expression of NLRP3. The inhibition of p-p38 and NF-κB were a critical
mechanism for the NLRP3 inflammasome suppressive effect of procyanidins in microglia
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of ROS and then suppressed the microglial NLRP3
inflammasome to attenuate morphine tolerance (Fig. 6).
Generation of IL-1β requires a priming signal and acti-
vating signal. The priming signal could be mediated by
pattern recognition receptor (PRRs) such as TLRs, which
would activate NF-κB (Fig. 6) [51]. The activated NF-κB
can promote the transcription of NLRP3 (Fig. 6); there-
fore, we further investigated the effect of procyanidins
on NF-κB activation. The mammalian NF-κB family
members can be regulated by upstream diverse signal
pathways, such as TLRs, TNF receptors, IL-1 receptors,
and MAPKs [52, 53]. It was confirmed that morphine
could activate TLR4, TNF-α, and IL-1β in microglia [54].
Furthermore, microglial p38 MAPK was dramatically
and primarily activated by chronic morphine exposure
in the spinal cord [27, 55, 56]. Indeed, our study revealed
procyanidins could sufficiently inhibit morphine-induced
NF-κB p65 nuclear translocation and remarkably re-
duced phosphorylation of p38 MAPK.
Morphine tolerance involves many receptors, chan-
nels, and processes. In a positive feedback loop, mor-
phine induces activation of microglia releasing a lot of
proinflammatory cytokines, which results in an extra-
excitation of sensor neurons in the spinal cord [57–59]
and decreases the efficiency of morphine analgesia
[60]. This process involves the activation of NMDA/
ERK/PKC signaling, which plays an important role in
morphine tolerance [6]. The proinflammatory cyto-
kines such as TNF-α and IL-1β activate NMDA recep-
tor by phosphorylating PKC followed by a strong
activation of ERK (Fig. 6). Then the phosphorylated
ERK and PKC can facilitate many channels and recep-
tors such as calcium channel on the cell membrane,
resulting in the central sensitization and morphine tol-
erance (Fig. 6) [6, 61, 62]. In this study, we found that
procyanidins notably inhibited the phosphorylation of
NMDA, ERK, and PKC in the spinal cord. In addition
to ERK and p38, we also found that procyanidins
significantly inhibited the phosphorylation of JNK,
which involved in the late stage of morphine tolerance
[63, 64]. It indicated that procyanidins might also have
significantly inhibitory effect in the late stage of mor-
phine tolerance.
Conclusions
In summary, procyanidins could extend acute morphine
analgesia and attenuate chronic morphine tolerance with
a possible biological mechanism of inhibiting neuroin-
flammation represented by microglia activation. Our re-
sults demonstrated that morphine exposure leading to
excess production of ROS from mitochondria, and that
procyanidins could diminish ROS and consequently
inhibit the activation of NLRP3 inflammasome in micro-
glia. Furthermore, procyanidins could suppress the over-
activated NF-κB and MAPKs signaling, which played im-
portant roles in morphine tolerance. Altogether, our
studies suggest that procyanidins may be a potential
drug candidate to reduce morphine tolerance and to en-
hance the clinical utility of opioid drugs.
Additional files
Additional file 1: Figures S1 and S2. BV2 cells were treated with
rotenone for 6 h with or without the pre-treatment of procyanidins. We
found that procyanidins could inhibit the upregulation of ROS which
induced by rotenone. Additional controls with procyanidins treatment
alone did not affect the baseline levels of NLRP3, pro-casp-1, casp-1,
pro-IL-1β, IL-1β, and TNF-α. (DOCX 237 kb)
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